Bill

Bill > HF590


IA HF590

IA HF590
A bill for an act relating to manufacturers and distributors of 340B drugs.


summary

Introduced
02/25/2025
In Committee
02/25/2025
Crossed Over
Passed
Dead

Introduced Session

91st General Assembly

Bill Summary

This bill relates to manufacturers and distributors of 340B drugs. “340B drug”, “manufacturer”, and “distributor” are defined in the bill. The bill prohibits a manufacturer or distributor from, directly or indirectly, denying, restricting, or interfering with the acquisition of a 340B drug by a covered entity, or the delivery of a 340B drug to a contract pharmacy, unless otherwise prohibited by the United States department of health and human services.

AI Summary

This bill addresses regulations for 340B drugs, which are prescription medications sold at a reduced price to certain healthcare providers under a federal program. The bill defines key terms: a "340B drug" is a covered outpatient drug purchased by a covered entity at a reduced price, a "distributor" is a wholesale drug seller that is not a manufacturer (including repackers, brokers, and warehouses), and a "manufacturer" is defined according to the federal Social Security Act. The core provision prohibits manufacturers and distributors from denying, restricting, or interfering with a covered entity's ability to acquire 340B drugs or have these drugs delivered to contract pharmacies, with the only exception being restrictions explicitly mandated by the U.S. Department of Health and Human Services. This legislation aims to protect the ability of eligible healthcare providers to access discounted medications through the 340B Drug Pricing Program, which helps safety-net healthcare providers serve vulnerable patient populations by reducing their drug acquisition costs.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Introduced, referred to Health and Human Services. H.J. 423. (on 02/25/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...